Merck & Co., Inc. (MRK) revenue & profit

Merck & Co., Inc. (MRK): revenue $65B, net income $18.3B in 2025; latest quarter +5.1% year over year. From SEC filings.

$65BRevenue 2025

TickerMRK (NYSE)

IndustryHealthcare · Pharmaceutical Preparations

Revenue 2025$65B

Net income 2025$18.3B

Net margin28.1%

Annual revenue growth+1.3%

Latest quarter (2026 Q2) · Revenue$16.6B

vs. same quarter last year+5.1%

Latest quarter · Net income-$1.3B

Annual revenue & net income

Year	Revenue	Net income
2022	$59.3B	$14.5B
2023	$60.1B	$365M
2024	$64.2B	$17.1B
2025	$65B	$18.3B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · Merck & Co. · Public domain · Wikimedia Commons

📷 Montgomery County Planning Commission · CC BY-SA 2.0 · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.